Sabestomig Clinical Trials
2 recruitingBiologic
Early Phase 12
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC
Head and Neck Squamous Cell Carcinoma
Presage Biosciences15 enrolled7 locationsNCT06366451
Recruiting
Early Phase 1
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Solid Tumor
Presage Biosciences15 enrolled12 locationsNCT04541108